Hyperion DeFi (HYPD) AI Stock Analysis

• Market Cap: $26.97M
• Dividend Yield: N/A
• Average Volume (3M): 1.09M
• Price to Earnings (P/E): ―
• Beta (1Y): 3.29
• Revenue Growth: 984.82%
• EPS Growth: 63.54%
• Country: US
• Employees: 13
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 0.05
• Shares Outstanding: 8,172,659
• 10 Day Avg. Volume: 701,310
• 30 Day Avg. Volume: 1,085,571
• PEG Ratio: -0.01
• Price to Book (P/B): -0.50
• Price to Sales (P/S): 114.63
• P/FCF Ratio: -0.22
• Enterprise Value/Market Cap: 1.39
• Enterprise Value/Revenue: 108.49
• Enterprise Value/Gross Profit: -13.23
• Enterprise Value/Ebitda: -1.61
• 1Y Price Target: $5.88
• Price Target Upside: 69.45% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: $3.50 ▲(0.86% Upside)

The score is held down primarily by weak financial performance (losses, negative gross profit, and heavy cash burn) and bearish technicals (below key moving averages with negative MACD). A more constructive earnings-call outlook and guidance provides partial support, but valuation signals are not informative due to negative earnings and no dividend yield.

Positive Factors

Revenue Growth

The substantial revenue growth indicates successful adoption of new business strategies and positions Hyperion DeFi for continued expansion in the DeFi sector.

Strategic Transformation

The strategic shift to focus on DeFi innovation enhances Hyperion's market relevance and potential for long-term growth in a rapidly evolving industry.

Partnership Expansion

The partnership enhances Hyperion's operational capacity and market positioning, potentially increasing its influence and revenue streams in blockchain validation.

Negative Factors

Regulatory Uncertainty

Regulatory uncertainty can hinder strategic planning and operational execution, posing risks to Hyperion's ability to navigate compliance in the DeFi space.

Negative Equity

Negative equity highlights financial instability, which can limit Hyperion's ability to invest in growth opportunities and manage financial obligations effectively.

HYPE Token Volatility

The volatility of the HYPE token poses financial risks, potentially impacting Hyperion's financial condition and strategic initiatives due to market fluctuations.

Hyperion DeFi Business Overview & Revenue Model

Company Description

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

How the Company Makes Money

Hyperion DeFi generates revenue primarily through transaction fees collected from users engaging in trading activities on its decentralized exchange and participating in liquidity pools. Additionally, the platform earns income from yield farming protocols by charging fees on the returns generated for users. Another key revenue stream involves partnerships with other blockchain projects and DeFi platforms, where Hyperion DeFi may receive a share of fees or commissions for facilitating transactions or providing liquidity. Moreover, any governance tokens issued by the platform could also provide a revenue model through staking rewards or secondary market sales.

Hyperion DeFi Financial Statement Overview

Summary

Eyenovia is facing significant financial challenges with high operational losses, negative profitability margins, and a precarious balance sheet. While revenue growth is a positive sign, the company's overall financial health is at risk due to negative equity and insufficient cash flow generation.

Income Statement

Eyenovia has shown considerable revenue growth from 2023 to 2024 but continues to face significant losses. The gross profit margin remains negative, and the net profit margin is significantly low due to high operational costs and expenses. EBIT and EBITDA margins are also deeply negative, indicating operational inefficiencies.

Balance Sheet

The company's financial leverage is concerning, with a negative stockholders' equity indicating potential financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, and the equity ratio is also negative, highlighting a risky financial structure.

Cash Flow

Eyenovia's cash flow remains negative, with decreasing free cash flow over the years. The operating cash flow to net income ratio is negative, suggesting inefficiencies in converting revenue into cash. Free cash flow to net income is also negative, indicating financial strain.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	345.32K	57.34K	3.79K	0.00	14.00M	2.00M
Gross Profit	-2.83M	-3.87M	-12.22K	0.00	12.40M	1.20M
EBITDA	-23.27M	-46.21M	-24.11M	-26.32M	-12.17M	-19.69M
Net Income	-25.50M	-49.82M	-27.26M	-28.01M	-12.78M	-19.77M
Balance Sheet
Total Assets	82.79M	3.67M	28.78M	31.04M	31.66M	33.91M
Cash, Cash Equivalents and Short-Term Investments	8.22M	2.12M	14.85M	22.86M	19.46M	28.37M
Total Debt	8.49M	11.24M	16.08M	10.12M	7.15M	463.35K
Total Liabilities	12.03M	16.76M	19.78M	13.80M	11.19M	18.60M
Stockholders Equity	70.76M	-13.10M	9.00M	17.23M	20.47M	15.30M
Cash Flow
Free Cash Flow	-62.32M	-30.28M	-27.81M	-25.98M	-22.49M	-6.65M
Operating Cash Flow	-16.82M	-30.12M	-23.84M	-25.11M	-20.87M	-6.38M
Investing Cash Flow	-65.64M	-161.48K	-3.97M	-874.75K	-1.62M	-261.26K
Financing Cash Flow	83.49M	17.55M	19.79M	21.51M	21.46M	20.86M

Hyperion DeFi Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.47
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYPD, the sentiment is Negative. The current price of 3.47 is below the 20-day moving average (MA) of 3.53, below the 50-day MA of 4.26, and below the 200-day MA of 5.71, indicating a bearish trend. The MACD of -0.22 indicates Negative momentum. The RSI at 44.27 is Neutral, neither overbought nor oversold. The STOCH value of 17.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HYPD.

Hyperion DeFi Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SRTS	65 Neutral	$78.18M	-24.96	-5.71%	―	-13.79%	-132.21%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HYPD	48 Neutral	$26.97M	-0.16	-68.49%	―	984.82%	63.54%
ICCM	45 Neutral	$48.79M	-2.63	-157.91%	―	-18.96%	8.98%
CTSO	44 Neutral	$42.14M	-3.69	-96.15%	―	-8.97%	47.29%
TELA	44 Neutral	$48.54M	-1.20	―	―	12.24%	47.45%

Hyperion DeFi Corporate Events

Hyperion DeFi Finalizes Leadership Team and Equity Conversion

On January 5, 2026, Hyperion DeFi converted 100,000 shares of its Series A Non-Voting Preferred Stock into 300,000 common shares, for no additional consideration, in an unregistered transaction relying on private offering exemptions, modestly shifting its capital structure toward common equity. Effective January 1, 2026, the board confirmed former interim CEO and current Chief Investment Officer Hyunsu Jung as permanent chief executive with a new employment agreement running through January 17, 2029, and on January 5, 2026, the company also announced the recent appointment of David Knox as chief financial officer and the upcoming arrival of veteran deal lawyer Robert Rubenstein as general counsel on January 12, 2026, collectively solidifying a leadership team aimed at strengthening governance, capital markets credibility and execution of its digital-asset-focused strategy.

The most recent analyst rating on (HYPD) stock is a Buy with a $7.75 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.

Hyperion DeFi Highlights Risks in HYPE Token Strategy

Hyperion DeFi has updated its risk factors, highlighting the volatility and risks associated with its HYPE token and treasury strategy. The company acknowledges the potential for significant financial impact due to the fluctuating value of HYPE, regulatory uncertainties, and technological challenges. The release outlines various risks, including market volatility, regulatory scrutiny, and technological vulnerabilities, which could affect the company’s financial condition and stock value. The company also notes the competitive landscape and the potential for emerging technologies to impact the demand for HYPE.

The most recent analyst rating on (HYPD) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.

Hyperion DeFi Enters $500M Sales Agreement

On November 14, 2025, Hyperion DeFi, Inc. entered into a Sales Agreement with Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC, allowing the company to offer and sell shares of its common stock through these sales agents. The agreement permits the company to sell shares with an aggregate offering price of up to $500 million, with sales executed in various transaction types, including block trades and at-the-market offerings. The sales agents will earn a 4% commission on the gross sales proceeds, and the offering will terminate upon the sale of all shares or termination of the agreement. This move is expected to impact Hyperion DeFi’s market positioning by potentially increasing its capital for further expansion and operations.

The most recent analyst rating on (HYPD) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.

Hyperion DeFi Reports Record Q3 2025 Net Income

On November 13, 2025, Hyperion DeFi announced its third-quarter financial results for the period ending September 30, 2025, reporting a record net income of $6.6 million. The company has undergone a significant transformation, pivoting from ophthalmic technology to becoming a leading institutional gateway for DeFi innovation. The company’s new digital asset treasury strategy has led to substantial financial growth, with revenue increasing from $1,625 in Q3 2024 to $302,506 in Q3 2025. Hyperion DeFi has also launched a co-brand validator, ‘Kinetiq x Hyperion,’ and has seen a 60% month-over-month increase in staked HYPE tokens. The company anticipates continued growth with positive operating cash flows expected in 2026.

The most recent analyst rating on (HYPD) stock is a Sell with a $5.50 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.

Hyperion DeFi Enters Joint Validator Agreement

On October 27, 2025, Hyperion DeFi entered a Joint Validator Agreement with Kinetiq Research and Pier Two to operate a co-branded validator node on the Hyperliquid blockchain, effective retroactively from June 25, 2025. This agreement involves shared responsibilities and revenue-sharing arrangements, enhancing Hyperion’s operational capacity and market positioning in blockchain validation. Additionally, Hyperion announced a strategic partnership with Felix to launch a perpetual futures market on the Hyperliquid protocol, leveraging 500,000 HYPE tokens. This partnership aims to expand Hyperliquid’s product suite and revenue streams, marking a significant step in decentralized finance innovation.

The most recent analyst rating on (HYPD) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.